This inventor holds 2 USPTO granted patents, plus 2 CIPO patents. Top assignee: Kanegafuchi Kagaku Kogyo Kabushiki Kaisha. Active years: 1990-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-1991
Title: Fumiyuki Kuze: Innovator in Antibacterial Research
Introduction
Fumiyuki Kuze is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of antibacterial research, particularly through his innovative work on rifamycin derivatives. With a total of two patents to his name, Kuze's inventions demonstrate a strong commitment to advancing medical science.
Latest Patents
Kuze's latest patents include a 3'-hydroxybenzoxazinorifamycin derivative and a substituted benzoxazinorifamycin derivative. The first patent describes a rifamycin derivative that exhibits strong antibacterial activity against Gram-positive bacteria, acid-fast bacteria, and tubercle bacilli. The compound is characterized by a specific formula where A is a group with defined alkyl or alkenyl characteristics. The second patent also focuses on a rifamycin derivative with similar antibacterial properties, detailing the chemical structure and potential applications in treating bacterial infections.
Career Highlights
Fumiyuki Kuze is associated with Kanegafuchi Kagaku Kogyo Kabushiki Kaisha, a company known for its research and development in chemical products. His work has been instrumental in creating effective antibacterial agents that can combat serious infections.
Collaborations
Kuze has collaborated with notable coworkers such as Takehiko Yamane and Takuji Hashizume. Their combined expertise has contributed to the successful development of innovative antibacterial solutions.
Conclusion
Fumiyuki Kuze's contributions to antibacterial research through his patents highlight his role as a significant inventor in the field. His work continues to impact medical science positively, showcasing the importance of innovation in combating bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
